I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Saturday, July 31, 2021

BRAVING CHEMO To University of Toledo Dana Cancer Center

Jan, Nursing Director
 and Melissa
Made a delivery of 5 copies of BRAVING CHEMO
to the University of Toledo Dana Cancer Center for patients undergoing treatment.
Also, hand-delivered a copy to a special friend who had just started chemotherapy.
Thank you again Beverly Zavaleta MD for your kindness of your sponsored books donation to help patients in my local community!


Order your copy here: BRAVING CHEMO

Jan, Nursing Director of University of
Toledo Dana Cancer Center

Your hard work & dedication to improving the lives of people undergoing #chemotherapy for #breastcancer is appreciated! - Beverly Zavaleta, MD

 

Thank you @mlsspaskvan for being an amazing #PatientAdvocated! - Beverly Zavaleta, MD

Total Pageviews



"click image to link"